Patent Term Extension Application for MYQORZO™ (aficamten), Patent No. 10,836,755 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-E-3818

Patent Term Extension Application for MYQORZO™ (aficamten), Patent No. 10,836,755

Documents

Comments

Description

OPEN

Comment Period OpensApr 9, 2026

Type	Title	Posted	Comments	Status
Other	Patent Term Extension Application from Morrison & Foerster LLP (Cytokinetics Incorporated)	Apr 9, 2026	--

CDER

Patent Term Extension Application

Morrison & Foerster LLP

Cytokinetics Incorporated

MYQORZO™ (aficamten)

Patent No. 10,836,755

OPEN